229 related articles for article (PubMed ID: 16046024)
1. Depressive symptoms of type 2 diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs: a Korean study.
Noh JH; Park JK; Lee HJ; Kwon SK; Lee SH; Park JH; Ko KS; Rhee BD; Lim KH; Kim DJ
Diabetes Res Clin Pract; 2005 Sep; 69(3):243-8. PubMed ID: 16046024
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
3. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
4. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
6. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings.
Shehatah A; Rabie MA; Al-Shahry A
J Affect Disord; 2010 Jun; 123(1-3):197-201. PubMed ID: 19804911
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial factors contributing to persistent depressive symptoms in type 2 diabetic patients: a Croatian survey from the European Depression in Diabetes Research Consortium.
Pibernik-Okanovic M; Begic D; Peros K; Szabo S; Metelko Z;
J Diabetes Complications; 2008; 22(4):246-53. PubMed ID: 18413168
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and costs of diabetes treated with insulin in France.
Detournay B; Raccah D; Cadilhac M; Eschwège E
Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.
Plastino M; Fava A; Pirritano D; Cotronei P; Sacco N; Sperlì T; Spanò A; Gallo D; Mungari P; Consoli D; Bosco D
J Neurol Sci; 2010 Jan; 288(1-2):112-6. PubMed ID: 19836029
[TBL] [Abstract][Full Text] [Related]
11. Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
Jeger RV; Seeberger MD; Keller U; Pfisterer ME; Filipovic M
Cardiology; 2007; 107(4):296-301. PubMed ID: 17264509
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients.
Tamer A; Karabay O; Ekerbicer H
Jpn J Infect Dis; 2006 Feb; 59(1):10-4. PubMed ID: 16495627
[TBL] [Abstract][Full Text] [Related]
13. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis.
Kalsekar ID; Madhavan SS; Amonkar MM; Douglas SM; Makela E; Elswick BL; Scott V
Clin Ther; 2006 Feb; 28(2):306-18. PubMed ID: 16678652
[TBL] [Abstract][Full Text] [Related]
14. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
Smooke S; Horwich TB; Fonarow GC
Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
[TBL] [Abstract][Full Text] [Related]
15. Are symptoms of depression more common in diabetes? Results from the Heinz Nixdorf Recall study.
Icks A; Kruse J; Dragano N; Broecker-Preuss M; Slomiany U; Mann K; Jöckel KH; Erbel R; Giani G; Moebus S;
Diabet Med; 2008 Nov; 25(11):1330-6. PubMed ID: 19046224
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
17. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care.
Park H; Hong Y; Lee H; Ha E; Sung Y
J Clin Epidemiol; 2004 Sep; 57(9):978-84. PubMed ID: 15504641
[TBL] [Abstract][Full Text] [Related]
18. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.
Vinik AI; Zhang Q
Diabetes Care; 2007 Apr; 30(4):795-800. PubMed ID: 17259481
[TBL] [Abstract][Full Text] [Related]
19. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
Kaymak Y; Taner E; Taner Y
Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
[TBL] [Abstract][Full Text] [Related]
20. Risk of depression in diabetes is highest for young persons using oral anti-diabetic agents.
Berge LI; Riise T; Fasmer OB; Lund A; Oedegaard KJ; Hundal O
Diabet Med; 2012 Apr; 29(4):509-14. PubMed ID: 22133020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
